Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | $0.06 | $0.06 | $0.06 |
Q2 2024 | 2 | $0.24 | $0.24 | $0.24 |
Q3 2024 | 3 | $0.18 | $0.18 | $0.18 |
Q4 2024 | 6 | -$0.10 | $0.05 | -$0.03 |
Q1 2025 | 6 | $0.07 | $0.14 | $0.10 |
Q2 2025 | 3 | $0.35 | $0.39 | $0.37 |
Q3 2025 | 3 | $0.27 | $0.30 | $0.29 |
Q4 2025 | 3 | $0.13 | $0.15 | $0.14 |
Q1 2026 | 2 | $0.05 | $0.05 | $0.05 |
Q2 2026 | 2 | $0.39 | $0.45 | $0.42 |
Q3 2026 | 2 | $0.33 | $0.37 | $0.35 |
Q4 2026 | 2 | $0.10 | $0.12 | $0.11 |
STAAR Surgical Company last posted its earnings results on Wednesday, October 30th, 2024. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.22. The company had revenue of 88.59 M for the quarter and had revenue of 322.42 M for the year. STAAR Surgical Company has generated $0 earnings per share over the last year ($0.43 diluted earnings per share) and currently has a price-to-earnings ratio of 56.08. STAAR Surgical Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/30/2024 | Q3 2024 | $0.19 | $0.20 | 0.01 | $86.90 M | $88.59 M |
08/07/2024 | Q2 2024 | $0.25 | $0.15 | -0.1 | $99.01 M | |
05/07/2024 | Q1 2024 | $0.05 | -$0.07 | -0.12 | $77.36 M | |
02/27/2024 | Q4 2023 | $0.16 | $76.27 M | |||
11/06/2023 | Q3 2023 | $0.10 | $80.31 M | |||
08/02/2023 | Q2 2023 | $0.32 | $0.13 | -0.19 | $92.31 M | |
05/03/2023 | Q1 2023 | $0.11 | $0.06 | -0.05 | $73.53 M | |
02/22/2023 | Q4 2022 | $0.12 | $64.04 M | |||
11/02/2022 | Q3 2022 | $0.21 | $0.21 | 0 | $76.05 M | |
08/10/2022 | Q2 2022 | $0.25 | $0.27 | 0.02 | $81.10 M | |
05/04/2022 | Q1 2022 | $0.16 | $0.20 | 0.04 | $63.20 M | |
02/23/2022 | Q4 2021 | $0.16 | $0.10 | -0.06 | $59.00 M | |
11/03/2021 | Q3 2021 | $0.16 | $0.13 | -0.03 | $58.35 M | |
08/04/2021 | Q2 2021 | $0.08 | $0.18 | 0.1 | $62.37 M | |
05/05/2021 | Q1 2021 | $0.01 | $0.11 | 0.1 | $50.75 M | |
02/24/2021 | Q4 2020 | $0.09 | $0.07 | -0.02 | $46.00 M | |
11/04/2020 | Q3 2020 | $0.09 | $0.08 | -0.01 | $47.08 M | |
08/05/2020 | Q2 2020 | $0.02 | -$0.03 | -0.05 | $35.19 M | |
05/06/2020 | Q1 2020 | $0.02 | -$0.00 | -0.02 | $35.19 M | |
02/26/2020 | Q4 2019 | $0.05 | $0.14 | 0.09 | $38.88 M |
STAAR Surgical Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates.
In the previous quarter, STAAR Surgical Company (:STAA) reported $0.41 earnings per share (EPS) to beat the analysts' consensus estimate of $0.19 by $0.22.
The conference call for STAAR Surgical Company's latest earnings report can be listened to online.
The conference call transcript for STAAR Surgical Company's latest earnings report can be read online.
STAAR Surgical Company (:STAA) has a recorded annual revenue of $322.42 M.
STAAR Surgical Company (:STAA) has a recorded net income of $322.42 M. STAAR Surgical Company has generated $0.44 earnings per share over the last four quarters.
STAAR Surgical Company (:STAA) has a price-to-earnings ratio of 56.08 and price/earnings-to-growth ratio is 1.91.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED